• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Biol Chem . Revealing novel and conservative T-cell epitopes with MHC B2 restriction on H9N2 Avian Influenza Virus (AIV)

tetano

Editor, Senior Moderator
J Biol Chem


. 2024 May 18:107395.
doi: 10.1016/j.jbc.2024.107395. Online ahead of print. Revealing novel and conservative T-cell epitopes with MHC B2 restriction on H9N2 Avian Influenza Virus (AIV)

Yusheng Jia[SUP] 1 [/SUP], Qingxin Wu[SUP] 1 [/SUP], Yilin Li[SUP] 1 [/SUP], Mulin Ma[SUP] 1 [/SUP], Wei Song[SUP] 1 [/SUP], Rongmao Chen[SUP] 1 [/SUP], Yongxiu Yao[SUP] 2 [/SUP], Venugopal Nair[SUP] 3 [/SUP], Nianzhi Zhang[SUP] 4 [/SUP], Ming Liao[SUP] 5 [/SUP], Manman Dai[SUP] 6 [/SUP]



Affiliations
Free article Abstract

B2 haplotype MHC has been extensively reported to confer resistance to various avian diseases. But its peptide-binding motif is unknown and the presenting peptide is rarely identified. Here, we identified the peptide-binding motif of B2 haplotype MHC Ⅰ molecules (X-A/V/I/L/P/S/G-X-X-X-X-X-X-V/I/L) in vitro using Random Peptide Library-based MHC-Ⅰ LC-MS/MS analysis. To further clarify the structure basis of the peptide binding motif, we determined the crystal structure of the BF2*02:01-PB2[SUB]552-560[/SUB] complex at 1.9 Å resolution. We found that BF2*02:01 had a relatively wide antigen-binding groove, and the structural characterization of pockets of BF2*02:01 was consistent with the characterization of peptide-binding motif. The wider features of the peptide-binding motif and increased number of peptides bound by BF2*02:01 than BF2*04:01 might resolve the puzzles for the presence of potential H9N2 resistance in B2 chickens. Afterwards, we explored the H9N2 AIV-induced cellular immune response in B2 haplotype chickens in vivo. We found that ratio of CD8[SUP]+[/SUP] T cell and kinetic expression of cytotoxicity genes including Granzyme K, IFN-γ, NK lysin, and PARP in PBMCs were significantly increased in defending against H9N2 AIV infection. Especially, we selected 411 epitopes as candidate epitopes based on the peptide-binding motif and further identified four CD8[SUP]+[/SUP] T-cell epitopes on H9N2 AIV including NS1[SUB]98-106[/SUB], PB2[SUB]552-560[/SUB], NP[SUB]182-190[/SUB], and NP[SUB]455-463[/SUB] via ELI-spot IFN-γ detections after stimulating memory lymphocytes with peptides. More importantly, these epitopes were found to be conserved in H7N9 AIV and H9N2 AIV. These findings provide direction for developing effective T cell epitope vaccines using well-conserved internal viral antigens in chickens.

Keywords: Crystal structure; H9N2 AIV; MHC B2 haplotype; Peptide-binding motif; T-cell epitope.

 
Back
Top Bottom